The Meals and Drug Administration first authorised the injectable medication for managing diabetic issues in 2017; the agency permitted a drug with a greater dose from the Lively ingredient in copyright, termed semaglutide, to treat obesity in 2021, beneath the manufacturer identify Wegovy. Given that then, talk with the drug has popped up across t